 | • レポートコード：TPM-BG125 • 出版社/出版日：Transparency Market Research / 2018年6月 • レポート形態：英文、PDF、185ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、ヘリコバクター・ピロリ用非侵襲性検査の世界市場について調べ、ヘリコバクター・ピロリ用非侵襲性検査の世界規模、市場動向、市場環境、検査種類別（血清学検査、便中抗原検査（SAT）、尿素呼気検査（UBT））分析、検査法別（検査室ベース検査・ポイントオブケア検査）分析、最終用途別（病院、クリニック、診断検査室）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・ヘリコバクター・ピロリ用非侵襲性検査の世界市場動向 ・ヘリコバクター・ピロリ用非侵襲性検査の世界市場環境 ・ヘリコバクター・ピロリ用非侵襲性検査の世界市場規模 ・ヘリコバクター・ピロリ用非侵襲性検査の世界市場規模：検査種類別（血清学検査、便中抗原検査（SAT）、尿素呼気検査（UBT）） ・ヘリコバクター・ピロリ用非侵襲性検査の世界市場規模：検査法別（検査室ベース検査・ポイントオブケア検査） ・ヘリコバクター・ピロリ用非侵襲性検査の世界市場規模：最終用途別（病院、クリニック、診断検査室） ・ヘリコバクター・ピロリ用非侵襲性検査の世界市場：地域別市場規模・分析 ・ヘリコバクター・ピロリ用非侵襲性検査の北米市場規模・予測 ・ヘリコバクター・ピロリ用非侵襲性検査のアメリカ市場規模・予測 ・ヘリコバクター・ピロリ用非侵襲性検査の中南米市場規模・予測 ・ヘリコバクター・ピロリ用非侵襲性検査のヨーロッパ市場規模・予測 ・ヘリコバクター・ピロリ用非侵襲性検査のアジア市場規模・予測 ・ヘリコバクター・ピロリ用非侵襲性検査の日本市場規模・予測 ・ヘリコバクター・ピロリ用非侵襲性検査の中国市場規模・予測 ・ヘリコバクター・ピロリ用非侵襲性検査のインド市場規模・予測 ・ヘリコバクター・ピロリ用非侵襲性検査の中東市場規模・予測 ・ヘリコバクター・ピロリ用非侵襲性検査のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market: Overview
This report studies the current as well as future prospects of the global Helicobacter pylori (H. pylori) non-invasive testing market. Over 50% of the world’s population is infected by H. pylori, and in some countries, the prevalence is higher than 80%. This is boosting the global Helicobacter pylori (H. pylori) non-invasive testing market. In 1994, the WHO’s, International Agency for Research on Cancer classified H. pylori as a Class 1 carcinogen.
This report on the Helicobacter pylori (H. pylori) non-invasive testing market comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to segments based on test type, test method, end-user, and geography. A detailed qualitative analysis of drivers, restraints, and trends has been provided in the market dynamics section. Additionally, the report comprises a list of new non-invasive H. pylori test launches by market players. The report describes epidemiological assessment of Helicobacter pylori, key technological advancements in Helicobacter pylori diagnostic testing, and market outlook and Porter’s Five Forces. The report provides a competition matrix in terms of current and future market positioning of key market players and their key differential parameters to help understand the competition landscape of the market. This report also provides market attractiveness and its analysis, in terms of geography, as well as market share analysis by test type, by test method, and end-user. Thus, the report presents a thorough analysis of the overall competitive scenario in the global Helicobacter pylori (H. pylori) non-invasive testing market.
Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market: Key Segments
Based on test type, the global Helicobacter pylori (H. pylori) non-invasive testing market has been segmented into serology test, stool antigen test (SAT), and urea breath test (UBT). The urea breath test (UBT) segment is expected to account for a prominent market share by the end of 2026, owing to factors such as rise in availability of the test, quick turnaround time for results of the test, and high accuracy rate for the detection of H. pylori infection. Among test methods, the laboratory-based tests segment held a prominent market share in 2017 and is expected to dominate the market during the forecast period, owing to the ability of the method to process large test volumes and trained professionals on site to carry out the tests in a controlled environment. In terms of end- user, the diagnostic laboratories segment is expected to hold a major market share fuelled by a large number of tests being carried out in standalone and hospital-affiliated diagnostic laboratories. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period (from 2018 to 2026), considering 2017 as the base year.
Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market: Regional Outlook
In terms of region, the global Helicobacter pylori (H. pylori) non-invasive testing market has been categorized into five major regions and key countries in the respective regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period (from 2018 to 2026), considering 2017 as the base year. The research study also covers the competition scenario in these regions.
Companies Mentioned in Report
The report also profiles major players operating in the global Helicobacter pylori (H. pylori) non-invasive testing market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Alere, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL, and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
The global Helicobacter pylori (H. pylori) non-invasive testing market has been segmented as follows:
Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type
Serology Test
Stool Antigen Test (SAT)
Urea Breath Test (UBT)
Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market, by Test Method
Laboratory-based Tests
Point-of-Care Tests
Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market, by End-user
Hospitals
Clinics
Diagnostic Laboratories
Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market, by Region
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary:Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Test Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.4. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecasts, 2016–2026
4.4.1. New Non-invasive H. Pylori Test launches, by Market Players
4.4.2. Epidemiological Assessment of Helicobacter Pylori
4.4.3. Key Technological Advancements in Helicobacter Pylori Diagnostic Testing
5. Market Outlook
5.1. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Forecast
5.2. Market Opportunity Map
5.3. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Outlook
5.4. Porter’s Five Forces Analysis
6. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecasts, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Non-invasive Test Type, 2016–2026
6.3.1. Serology Test
6.3.2. Stool antigen test (SAT)
6.3.3. Urea Breath Test (UBT)
6.4. Market Attractiveness, by Non-invasive Test Type
7. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecasts, by Test Method
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Test Method, 2016–2026
7.3.1. Laboratory Based Tests
7.3.2. Point-of-Care Tests
7.4. Market Attractiveness by Test Method
8. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecasts, by End User
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End User, 2016–2026
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Diagnostic Laboratories
8.4. Market Attractiveness, by End User
9. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Non-invasive Test Type, 2016–2026
10.2.1. Serology Test
10.2.2. Stool antigen test (SAT)
10.2.3. Urea Breath Test (UBT)
10.3. Market Value Forecast, by Test Method, 2016–2026
10.3.1. Laboratory Based Tests
10.3.2. Point-of-care Tests
10.4. Market Value Forecast, by End User, 2016–2026
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Diagnostic Laboratories
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Non-invasive Test Type
10.6.2. By Test Method
10.6.3. By End User
10.6.4. By Country
11. Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Non-invasive Test Type, 2016–2026
11.2.1. Serology Test
11.2.2. Stool antigen test (SAT)
11.2.3. Urea Breath Test (UBT)
11.3. Market Value Forecast, by Test Method, 2016–2026
11.3.1. Laboratory Based Tests
11.3.2. Point-of-care Tests
11.4. Market Value Forecast, by End User, 2016–2026
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Diagnostic Laboratories
11.5. Market Value Forecast, by Country, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Non-invasive Test Type
11.6.2. By Test Method
11.6.3. By End User
11.6.4. By Country
12. Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Non-invasive Test Type, 2016–2026
12.2.1. Serology Test
12.2.2. Stool antigen test (SAT)
12.2.3. Urea Breath Test (UBT)
12.3. Market Value Forecast, by Test Method, 2016–2026
12.3.1. Laboratory Based Tests
12.3.2. Point-of-care Tests
12.4. Market Value Forecast, by End User, 2016–2026
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Diagnostic Laboratories
12.5. Market Value Forecast, by Country, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Non-invasive Test Type
12.6.2. By Test Method
12.6.3. By End User
12.6.4. By Country
13. Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Non-invasive Test Type, 2016–2026
13.2.1. Serology Test
13.2.2. Stool antigen test (SAT)
13.2.3. Urea Breath Test (UBT)
13.3. Market Value Forecast, by Test Method, 2016–2026
13.3.1. Laboratory Based Tests
13.3.2. Point-of-Care Tests
13.4. Market Value Forecast, by End User, 2016–2026
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Diagnostic Laboratories
13.5. Market Value Forecast by Country, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Non-invasive Test Type
13.6.2. By Test Method
13.6.3. By End User
13.6.4. By Country
14. Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Non-invasive Test Type, 2016–2026
14.2.1. Serology Test
14.2.2. Stool antigen test (SAT)
14.2.3. Urea Breath Test (UBT)
14.3. Market Value Forecast, by Test Method, 2016–2026
14.3.1. Laboratory Based Tests
14.3.2. Point-of-Care Tests
14.4. Market Value Forecast, by End User, 2016–2026
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Diagnostic Laboratories
14.5. Market Value Forecast, by Country, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Non-invasive Test Type
14.6.2. By Test Method
14.6.3. By End User
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company (2017),Estimated
15.3. Market Footprint Analysis
15.3.1. By Region
15.3.2. By Non-invasive Test Type
15.4. Competitive Business Strategies
15.5. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)*
15.5.1. DiaSorin S.p.A.
15.5.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.5.1.2 Financial Overview
15.5.1.3 Product Portfolio
15.5.1.4 SWOT Analysis
15.5.1.5 Strategic Overview
15.5.2. Meridian Bioscience, Inc.
15.5.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.5.2.2 Financial Overview
15.5.2.3 Product Portfolio
15.5.2.4 SWOT Analysis
15.5.2.5 Strategic Overview
15.5.3. Exalenz Bioscience Ltd.
15.5.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.5.3.2 Financial Overview
15.5.3.3 Product Portfolio
15.5.3.4 SWOT Analysis
15.5.3.5 Strategic Overview
15.5.4. Alere
15.5.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.5.4.2 Financial Overview
15.5.4.3 Product Portfolio
15.5.4.4 SWOT Analysis
15.5.4.5 Strategic Overview
15.5.5. Thermo Fisher Scientific
15.5.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.5.5.2 Financial Overview
15.5.5.3 Product Portfolio
15.5.5.4 SWOT Analysis
15.5.5.5 Strategic Overview
15.5.6. Biomerica, Inc.
15.5.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.5.6.2 Financial Overview
15.5.6.3 Product Portfolio
15.5.6.4 SWOT Analysis
15.5.6.5 Strategic Overview
15.5.7. Certest Biotec S.L.
15.5.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.5.7.2 Financial Overview
15.5.7.3 Product Portfolio
15.5.7.4 SWOT Analysis
15.5.7.5 Strategic Overview
15.5.8. Sekisui Diagnostics
15.5.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.5.8.2 Financial Overview
15.5.8.3 Product Portfolio
15.5.8.4 SWOT Analysis
15.5.8.5 Strategic Overview
15.5.9. CorisBioconcept SPRL
15.5.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.5.9.2 Financial Overview
15.5.9.3 Product Portfolio
15.5.9.4 SWOT Analysis
15.5.9.5 Strategic Overview
15.5.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
15.5.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
15.5.10.2 Financial Overview
15.5.10.3 Product Portfolio
15.5.10.4 SWOT Analysis
15.5.10.5 Strategic Overview
*Note: Financial details for companies that do not report this information in public domain might not be captured.
List of TablesTable 01: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 02: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, by Test Method, 2016–2026
Table 03: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, by End User, 2016–2026
Table 04: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 07: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Test Method, 2016–2026
Table 08: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by End User, 2016–2026
Table 09: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 10: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 11: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Test Method, 2016–2026
Table 12: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by End User, 2016–2026
Table 13: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 14: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 15: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Test Method, 2016–2026
Table 16: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by End User, 2016–2026
Table 17: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 18: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 19: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Test Method, 2016–2026
Table 20: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by End User, 2016–2026
Table 21: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 22: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 23: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Test Method, 2016–2026
Table 24: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by End User, 2016–2026